QHSLab, Inc. revenue by segment USAQ

Annual Quarterly

QHSLab, Inc. splits its revenue into 7 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Integrated Service Program at $491,399, 58% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024	Q3 FY2024 Sep 30, 2024
Revenue	3	1	1	1	1	1	1	1	1
Integrated Service Program	2 +99.6% share 51.7%	0 +86.4% share 58.0%	0 +130.5% share 51.4%	—	—	0 share 43.5%	0 share 25.2%	0 share 31.0%	—
Allergy Diagnostic Kit Sales	1 -9.5% share 26.0%	0 -0.8% share 23.1%	0 share 31.4%	0 share 20.5%	0 -1.7% share 29.4%	0 share 32.6%	—	—	0 share 40.4%
Immunotherapy Treatment Sales	0 +1.8% share 15.1%	0 -21.6% share 11.1%	0 share 12.5%	0 -16.5% share 19.8%	0 +105.8% share 17.8%	0 share 19.8%	—	0 share 26.6%	0 share 11.7%
Clinical Study Revenue	—	—	—	0 -25.0% share 6.3%	—	—	0 share 13.8%	0 share 9.5%	—
Shipping And Handling	0 +18.9% share 1.5%	0 +8.2% share 1.3%	0 +16.8% share 1.6%	0 +14.0% share 1.4%	0 +40.2% share 1.6%	0 share 1.7%	0 share 1.5%	0 share 1.4%	0 share 1.5%
Training And Other Revenue	—	—	0 -12.7% share 1.5%	—	0 -23.7% share 0.3%	0 share 0.8%	0 share 1.9%	0 share 0.5%	0 share 0.6%
Subscription Revenue	0 +8.6% share 1.5%	0 -28.0% share 0.8%	0 +28.7% share 1.6%	0 +3.7% share 1.3%	0 share 2.2%	0 share 1.5%	0 share 1.4%	0 share 1.4%	—

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: USAQ (OTC)
Fiscal year ends: December 31
Incorporated in: NV
Headquarters: West Palm Beach, FL
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 856984
Former names: USA EQUITIES CORP. (until Apr 19, 2022); AMERICAN BIOGENETIC SCIENCES INC (until Nov 16, 2015)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.